Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 Gy TBI Before CAR T Cell Therapy in Acute Lymphoblastic Leukemia
NCT07856758Not yet recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2027
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Open-label trial in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: CAR T-cell level and Safety and Adverse Events. Planned start Mar 2027; status: not yet recruiting.
02
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT07856758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07856758.